(b)(6).(b)(4).An ultraflex tracheobroncial covered stent was received for analysis; the delivery system was not returned.Visual examination of the returned device found the stent was deformed, stent was unraveled, and stent retention suture was broken.No other issues were noted to the stent.The reported event of stent failure to deploy was not confirmed.There was no confirmation of stent failure to deploy as the customer indicated because the shaft was not returned and the stent was returned completely deployed.However, taking all available information into consideration, the investigation concluded that the reported event and observed problems may have been related to procedural factors.It may be that factors during the procedure limited the performance of the device and contributed to the damages noted on the stent and the stent suture leading to the stent deployment failure.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to the procedure.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.A labeling review was performed and from the information available, this device was used per the ifu (instructions for use) / product label.
|
It was reported to boston scientific corporation that an ultraflex tracheobronchial covered distal release stent was to be implanted in the trachea during a procedure performed on (b)(6) 2021.During the procedure, the stent failed to deploy.The procedure was completed with another ultraflex tracheobronchial stent.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: this event has been deemed a mdr-reportable event based on investigation results which revealed that the stent was deformed, unraveled and the stent retention suture was broken.
|